Clinical trial

Omnipod® 5 Automated Insulin Delivery System in Patients With Type 2 Diabetes

NCT04617795

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-11-23

PhaseNA

Study timeline

Study start (actual)2020-11-23Date precision: day

Registry last updated2025-04-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

Omnipod 5 Automated Insulin Delivery SystemDEVICE

Sponsors & collaborators

Insulet Corporationlead sponsor

Mapped research locations

AtlantaGeorgia, United States2 Los AngelesCalifornia, United States1 Saint Louis ParkMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04617795 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.